JAVITT JONATHAN C (Chief Executive Officer) purchased 215.8% of their position (100K shares) of NRX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $5.80M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/2/2022ACC: 0000921895-22-001872
DirectorOfficer10% Owner· Chief Executive Officer
Since May 2021
+100K
Net shares
Net buyer
$5.80M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+100K
Price / share
$58.00
Trade value
$5.80M
% of position
215.8%
6/1/2022
46.33K→146.33K
Total
Net shares
+100K
Net value
$5.80M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2022 | P · Purchase | +100K | $58.00 | $5.80M | 215.8% | 46.33K | 146.33K |
| Total | +100K | $5.80M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.42M
Common Stock
IndirectShares owned13.30M
Total
14.72M indirect14.72M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.42M | Indirect |
| Common Stock | 13.30M | Indirect |
| Total | 14.72M | 14.72M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported